Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

  • STATUS
    Recruiting
  • End date
    Dec 22, 2023
  • participants needed
    50
  • sponsor
    Sherief Abd-Elsalam
Updated on 22 January 2021
platelet count
carcinoma
serum bilirubin
TACE
radiofrequency ablation
chemoembolization
hepatocellular carcinoma
unresectable hepatocellular carcinoma

Summary

Hepatocellular carcinoma is the third most common cause of cancer-related mortality. In recent years, transarterial chemoembolization, radio frequency ablation and microwave ablation have been accepted as treatment modalities for patients with surgically unresectable hepatocellular carcinoma.

Description

To compare between combination treatment with radiofrequency or microwave ablation followed by transarterial chemoembolization and performed in a single session.

Details
Condition HEPATIC NEOPLASM, Liver Cancer, Liver Cancer, Biliary Tract Cancer, cancer, liver, cancer, hepatic, cancer, hepatocellular, liver cancers
Treatment Transarterial chemoembolization (TACE), Radiofrequency ablation combined with TACE, Microwave ablation combined with TACE
Clinical Study IdentifierNCT02646137
SponsorSherief Abd-Elsalam
Last Modified on22 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Child classification A or B
serum albumin 3 gm/L
serum bilirubin < 2.5 mg/dL
platelet count 70,000 mm3
INR 1.6
serum creatinine < 2 mg/dl
tumor size more than 4 cm and confined to one lobe of the liver

Exclusion Criteria

Patients with portal vein thrombosis
A technically inaccessible hepatic artery
Metastatic HCC
More than three lesions
lesions in close proximity to the portal vein (PV),inferior vena cava (IVC) or gall bladder were excluded from the study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note